226
Participants
Start Date
January 31, 2005
Primary Completion Date
May 31, 2006
Study Completion Date
liraglutide
Novo Nordisk Investigational Site, Tokyo
Lead Sponsor
Novo Nordisk A/S
INDUSTRY